Related Experiment Video
Updated: Apr 18, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
BRAF overexpression induces rampant glioma proliferation independent of phospho-EGFR expression
Mei Li1, Minghai Wei2, Zhenfu Jiang2
1Laboratory Center, The Second Hospital of Dalian Medical University, Dalian, The People's Republic of China.
Background:
The prognosis for gliomas is still dismal when treated with traditional approaches. Molecular targeted therapy has become a trend in treating tumors, including gliomas. However, molecular characteristics vary among different kinds of tumors and ethnic groups.
Objectives:
The aim of the research was to study the expression characteristics of key components in the EGFR pathway of gliomas in order to contribute new data for the molecular targeted treatment of gliomas.
Material And Methods:
EGFR, KRAS, BRAF, PI3K, phospho-EGFR and Ki67 expression were detected with immunohistochemistry in 82 glioma specimens.
Results:
The expression of EGFR was positively correlated with the patients' age. There were no significant differences in clinicopathological characteristics between gliomas with and without phospho-EGFR expression. EGFR overexpression was significantly correlated with phospho-EGFR expression. In gliomas with EGFR activation, overexpressions of EGFR, BRAF and PI3K were significantly correlated with proliferation. However, in gliomas without phospho-EGFR expression, only BRAF overexpression was significantly related to the proliferation of tumor cells.
Conclusions:
BRAF overexpression could be an independent factor causing tumorigenesis in gliomas regardless of phospho-EGFR expression. The molecular characteristics can vary with the increasing age of glioma patients.
Insights
BRAF overexpression drives glioma development independently of EGFR activation. Molecular profiles in gliomas vary with patient age, impacting targeted therapy strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioma prognosis remains poor with conventional treatments.
- Molecular targeted therapy is a growing trend for gliomas.
- Tumor molecular characteristics differ across tumor types and ethnicities.
Purpose of the Study:
- Investigate EGFR pathway component expression in gliomas.
- Provide data for molecular targeted glioma treatment.
- Understand variations in glioma molecular profiles.
Main Methods:
- Immunohistochemistry used to detect EGFR, KRAS, BRAF, PI3K, phospho-EGFR, and Ki67 expression.
- Study included 82 glioma specimens.
- Correlated molecular markers with clinicopathological features.
Main Results:
- EGFR expression correlated positively with patient age.
- EGFR overexpression linked to phospho-EGFR expression.
- In EGFR-activated gliomas, EGFR, BRAF, and PI3K overexpression correlated with proliferation.
- In non-phospho-EGFR gliomas, BRAF overexpression alone related to proliferation.
Conclusions:
- BRAF overexpression is an independent driver of glioma tumorigenesis.
- EGFR pathway activation influences proliferation differently based on phospho-EGFR status.
- Glioma molecular characteristics are age-dependent.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
The Ras Gene
Ras is a...
PI3K/mTOR/AKT Signaling Pathway

